Every 2 years, the Canadian Community Health Survey gathers health-related data of Canadian inhabitants at the regional level. The 2019 survey in Ontario reported 23% of >14,000 adolescents in student grades 7–12 as e-cigarette (EC) smokers, a marked rise from the previous survey. “Our study asks the following questions: do EC users have an increased risk of asthma, and if so, do they incur higher odds of an asthma attack,” Prof. Theresa To (The Hospital for Sick Children, ON, Canada) explained [1]. The new cross-sectional study was based on data from individuals aged ≥12 years partaking in 2 cycles of the Canadian Community Health Survey dated 2015/2016 and 2017/2018 [2]. For the case-control design, cases were defined as those self-reporting EC smoking within the last 30 days. To each case, 5 non-vaping controls were matched by age, sex, BMI, smoking, and socioeconomic status, employing a propensity score. The latter is a common statistic technique to reduce bias due to confounding variables in observational studies.
Together, the study included 17,190 matched subjects of whom 3.1% met the criteria of EC users. Hence, 1 in 32 participants smoked EC within the last 30 days. The logistic regression that controlled for potential confounders associated with asthma, including the variables utilised for the propensity score, identified 19% elevated odds of asthma in EC-using persons. Moreover, EC-vaping individuals with asthma had a 24% higher likelihood of having experienced an asthma attack in the last year. Interestingly, 50% of EC users also smoked cigarettes on a daily basis, whereas only 15% in the group not using EC did. “Of the EC users, about 15% reported fair to poor mental health compared with 7% amongst non-user,” Prof. To further elaborated. “These findings suggest that EC use is a modifiable risk factor for asthma to be considered in the primary care of youths and adults,” concluded Prof. To.
- To T, et al. Does Vaping Increase the Odds of Asthma? A Canadian Community Health Survey Study. Session TP16: Clinical and research updates on tobacco cessation, vaping, and e-cigarettes. ATS 2021 International Conference, 14-19 May.
- Mehra VM, et al. BMC Public Health 2019;19(1):1208.
Copyright ©2021 Medicom Medical Publishers
Posted on
Previous Article
« Advanced cystic fibrosis – improved lung function with long-term triple therapy Next Article
Tobacco biomarkers do not improve prediction of lung cancer risk »
« Advanced cystic fibrosis – improved lung function with long-term triple therapy Next Article
Tobacco biomarkers do not improve prediction of lung cancer risk »
Table of Contents: ATS 2021
Featured articles
Letter from the Editor
COVID-19: What Pulmonologists Need to Know
Antibody treatment for COVID-19: a combination is successful
Air pollution: an underestimated negative prognostic factor for COVID-19
Healthcare workers vulnerable to SARS-CoV-2 infections
Genetic risk variants responsible for COVID-19 predisposition
Asthma – An Update
“As-needed” inhaled corticosteroid therapy for mild asthma – what is the evidence?
IL-4/13 blocker successful in treatment of paediatric moderate-to-severe asthma
Benralizumab lives up to its phase 3 results in real-world findings
Tezepelumab – good success rates in various types of severe asthma
Sleep Disorders – An Underestimated Problem
OSA: A risk factor for earlier cognitive decline
Subgroup of patients with high heart rate response and coronary artery disease benefit from CPAP
Association between positive airway pressure treatment adherence and COVID-19 infection rates
COPD – What Is New
Possible aetiologies for COPD exacerbations – more evidence is needed
Does COPD plus COVID-19 equal higher mortality?
Biomarkers for acute exacerbations in COPD are required
Severe exacerbations: A key driver of all-cause mortality in COPD patients
Men and women with COPD differ in many ways
Younger adults with COPD at higher health risk than previously thought
Metabolic Dysregulation and Lung Disease
Obesity: A risk factor for new-onset asthma and worse asthma control
Metabolic dysfunction and lung disease: children are no small adults
Best of the Posters
Air pollution in winter linked to more hospital admissions in ILD patients
Tobacco biomarkers do not improve prediction of lung cancer risk
Vaping identified as risk factor for asthma
Related Articles
July 18, 2022
New guidelines for IPF and PPF
November 7, 2018
Gastroesophageal reflux, IPF and lessons learned
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com